Wajeeha Rizvi, MD

Dr. Wajeeha Rizvi is a board-certified Hematologist and Medical Oncologist currently serving as an Associate Physician at Quincy Medical Group Cancer Institute, where she also chairs the Cancer Committee and directs the Tumor Board. She completed her fellowship at West Virginia University and residency at Kansas University School of Medicine. Dr. Rizvi has authored numerous peer-reviewed publications on breast cancer, hematologic malignancies, and healthcare quality improvement. Her active involvement in professional societies and academic mentorship underscores her dedication to advancing oncology care and education.

• The American Board of Internal Medicine Certified: 2019 - Present
• The American Board of Internal Medicine-Hematology: 2021 - Present
• The American Board of Internal Medicine-Medical Oncology: 2022 - Present

Peer Reviewed Journal Articles / Abstracts

1. Salkeni MA, Rizvi W, Hein K, Higa GM. Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer. Breast Cancer (Dove Med Press). 2021 Sep 24;13:539-557. doi: 10.2147/BCTT.S288344. PMID: 34602823; PMCID: PMC8481821

2. Optimizing the fellow oncology continuity clinic: Factors associated with a meaningful experience.

Carl Shultz, Wajeeha Rizvi, Salah Ud Din Safi, Maria Hafez, Jean Gabriel Bustamante Alvarez, Nour Daboul, Amir Kamran
Journal of Clinical Oncology 2022 40:16_suppl, e23012-e23012

3. Healthcare survey to assess the impact of face masks during clinic visits among Cancer patients and Care providers

Wajeeha Rizvi, Salahuddin Safi, Ahmad Cheema, Amir Kamran. West Virginia University School of Medicine, Department of Medicine, Section of Hematology/Oncology, Morgantown, WV (Manuscript submitted-2024)

4. Multiple Myeloma and Factor X Mystery - A Case Report presented in WV-ACP 2021 Joshua Bellamy, MD; Wajeeha Rizvi, MD; Salahuddin Safi, MD; Kelly Ross, MD Departments of Medicine, West Virginia University School of Medicine

5. Effective Management of Obesity with Generic Combination of Phentermine/Topiramate vs Qsymia®: Is it Possible? Wajeeha Rizvi, M.D., Nicholas Ojile, M.D., Milan Bimali, Ph.D., K James Kallail, Ph.D., Georges Elhomsy, M.D Kansas Journal of Medicine Volume 11, Supplement 2, 2018

6. Rizvi W, Truong Q: Unusual Relapse of Chronic Lymphocytic Leukemia After Remission.ANTICANCER RESEARCH 38: 1827-1843 (2018) doi: 10.21873/anticanres.12422

7. Rizvi W, Truong P, Truong Q.: Metastatic Breast Cancer with BRCA Mutation Discovered By Next-Generation Sequencing Responding to Olaparib. Cureus. 2017 Jun 11; 9(6): e1337. doi: 10.7759/cureus.1337. PMID: 28706762

8. Rizvi W, Munguti CM, Mehta J, Kallail KJ, Youngman D, Antonios S.: Reducing Over-Utilization of Cardiac Telemetry with Pop-Ups in an Electronic Medical Record System. Cureus. 2017 May 29;9(5):e1282. doi: 10.7759/cureus.1282. PMID: 28680770

9. Rowe, Kyle. Ndunda, Paul, Rizvi, W H., Witherspoon, K.,: Fatal acute liver failure due to primary herpes simplex virus infection. Kansas Chapter American College of Physician meeting

10. Rizvi,W., Hayat,N., Jamshed,A., Jamil,S.Bin.: Head and neck/ Depression among head and neck cancer patients undergoing curative radiotherapy. Radiotherapy & Oncology - Journal of the European Society for Therapeutic Radiology and Oncology. 2010, Sep; Vol.96, Supplement 1(ISSN- 0167-8140): S 313.

• Breast care Award at Annual Breast cancer symposium by Targeted Medical Education-Breast Care Network, November 2017
• Winning Article award in the “Exceptional responders in breast cancer” publishing competition by Cureus Journal of Medical Science, August 2017.
• Annual American College of Physician finalist March 2017. Topic of Study was Reducing Overutilization of Cardiac Telemetry with Pop-ups in EMR.
• Awarded Best Intern - Karachi Pakistan | 2012

• Medical License in United States: Kansas, West Virginia, Illinois (Currently active)
• Pakistan Medical and Dental Association Medical License